WELLS FARGO & COMPANY/MN - ACURX PHARMACEUTICALS INC ownership

ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 13 filers reported holding ACURX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116
-32.6%
77
+18.5%
0.00%
Q2 2023$172
-20.0%
65
+4.8%
0.00%
Q1 2023$215
-11.5%
62
+1.6%
0.00%
Q4 2022$24361
+5.2%
0.00%
Q3 2022$058
+222.2%
0.00%
Q2 2022$018
+12.5%
0.00%
Q1 2022$0160.0%0.00%
Q4 2021$016
+6.7%
0.00%
Q3 2021$0150.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Draper Asset Management, LLC 266,025$1,058,7801.47%
ARMISTICE CAPITAL, LLC 880,000$3,502,4000.06%
Semmax Financial Advisors Inc. 5,879$240.01%
Belpointe Asset Management LLC 3,000$11,9400.00%
TD Waterhouse Canada Inc. 18,656$77,4220.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 10,100$40,1980.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 77,283$3070.00%
MILLENNIUM MANAGEMENT LLC 29,096$1160.00%
BlackRock Inc. 15,639$62,2430.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders